Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Tooth extractions in patients with cancer receiving high-dose antiresorptive medication: a randomized clinical feasibility trial of drug holiday versus drug continuation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Implant treatment after traumatic tooth loss: A systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Bone Regeneration in Membrane-Protected Defects

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologi

  3. Fully versus conventionally guided implant placement by dental students: A randomized controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVE: Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction to high-dose antiresorptive medication (AR) in patients with cancer. A temporary discontinuation of AR (drug holiday) has been suggested to potentially reduce the risk of MRONJ after oral surgery. However, no consensus exists. The aim of the present feasibility trial was to evaluate the impact of a high-dose AR drug holiday in connection with surgical tooth extraction on the development of MRONJ and patient-reported health state.

STUDY DESIGN: Patients with cancer receiving high-dose AR were randomized to a drug holiday from 1 month before to 3 months after surgical tooth extraction or drug continuation. Follow-up was scheduled at 1, 3, and 6 months postoperatively. Patient health state was evaluated using the EQ-5D-5L questionnaire.

RESULTS: The study included 23 patients (11 men, 12 women). AR included denosumab (n = 13) and bisphosphonate (n = 10) with median AR durations of 9 and 17.5 months, respectively. Four denosumab patients from the drug holiday group developed MRONJ. Differences in EQ-5D-5L between the treatment groups were found in favor of drug continuation.

CONCLUSIONS: The results indicate that a high-dose AR drug holiday does not prevent development of MRONJ after surgical tooth extraction and that patient-reported health state declines during a drug holiday compared with drug continuation.

OriginalsprogEngelsk
TidsskriftOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Vol/bind133
Udgave nummer2
Sider (fra-til)165-173
Antal sider9
ISSN2212-4403
DOI
StatusUdgivet - feb. 2022

Bibliografisk note

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

ID: 70403317